What is dextrose 5% (five percent) infusion continuous?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dextrose 5% Infusion Continuous

Dextrose 5% (D5W) is an isotonic intravenous solution containing 5% glucose (50g/L) in water that becomes hypotonic once administered, providing free water and approximately 170 calories per liter without electrolytes. It is commonly used for free water administration, as a vehicle for medication delivery, and in specific clinical scenarios requiring glucose supplementation.

Composition and Properties

  • Concentration: Contains 5 grams of dextrose per 100 mL (5% w/v)
  • Osmolarity: Initially isotonic at approximately 278 mOsm/L before administration
  • Tonicity: Becomes hypotonic after glucose metabolism
  • Caloric content: Provides 170 calories per liter (3.4 kcal/g of dextrose)
  • pH: Approximately 4.0

Clinical Applications

Primary Uses

  • Free water replacement in patients with hypernatremia or hyperosmolality
  • Vehicle for medication delivery when electrolyte-free solutions are preferred
  • Glucose supplementation in specific clinical scenarios:
    • Hypoglycemia management (though higher concentrations like D10W or D50W are typically used for acute treatment)
    • Prevention of hypoglycemia during insulin administration 1
    • Management of hyperkalemia (when combined with insulin)

Specific Clinical Scenarios

  1. Beta-blocker overdose management:

    • Used in high-dose insulin-euglycemia therapy protocols
    • Administered at 0.5 g/kg/hour alongside insulin infusions
    • Titrated to maintain serum glucose between 100-250 mg/dL 1
  2. Hypovolemic hypernatremia:

    • Used after initial volume restoration with isotonic solutions
    • Helps correct hypernatremia while providing free water 2
    • Various formulations include D5 0.45% NaCl (half-normal saline with 5% dextrose)
  3. Nephrogenic diabetes insipidus:

    • Used as maintenance fluid when patients cannot self-regulate fluid intake
    • Provides free water without additional osmotic load 1

Administration Considerations

Monitoring Requirements

  • Blood glucose: Regular monitoring (every 15-30 minutes initially) is essential during administration, especially with higher infusion rates 1
  • Serum electrolytes: Monitor for development of hyponatremia, particularly in at-risk patients
  • Fluid status: Assess for signs of fluid overload

Precautions and Contraindications

  • Not recommended for volume resuscitation in hypovolemic states (isotonic crystalloids preferred)
  • Use with caution in patients at risk for cerebral edema 2
  • Avoid in patients with severe hyperglycemia or diabetic ketoacidosis
  • Central venous access required for sustained infusions of concentrated dextrose solutions (>10%) 1

Physiological Effects

  • Continuous D5W infusion at 100 mL/hr typically raises serum glucose by approximately 9 mg/dL above baseline
  • At 200 mL/hr, serum glucose may increase by approximately 24 mg/dL above baseline 3

Potential Complications

  • Hyperglycemia: Especially in stress states or with higher infusion rates
  • Hyponatremia: Due to free water effect after glucose metabolism
  • Fluid overload: If administered too rapidly or in excessive volumes
  • Tissue damage: If extravasation occurs (less concerning than with higher dextrose concentrations)
  • Electrolyte disturbances: Particularly hypokalemia when combined with insulin therapy 1

D5W should be used judiciously based on specific clinical indications, with appropriate monitoring of glucose levels, electrolytes, and fluid status to prevent complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypovolemic Hypernatremia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Effect of intravenous glucose on serum glucose determinations.

Metabolism: clinical and experimental, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.